Revenue

Everest Group recognizes CGI's role in India's booming GCC market, where hubs for digital transformation and AI now balance innovation with efficiency.

The software giant is launching AI-powered AP automation, mobile payments, and integrated financing to tackle contractor cash flow and operational headaches.

How a blend of private capital and pragmatic regulation is turning Singapore into a global hub for longevity research, pushing scientific and ethical boundaries.

As the eVTOL race intensifies, Vertical Aerospace appoints key execs from Lotus, Nike, and AB InBev to spearhead its push for certification and scale.

The UK charity is launching The Waqf Fund, blending ancient Islamic finance with modern investment to create a self-sustaining model for global aid.

CEO Werner Lanthaler will present FairJourney Bio's data-driven antibody discovery platform at the elite J.P. Morgan conference, signaling major growth.

The demo automation leader launched a new partner network, promising to connect disparate sales and marketing tools into a single, cohesive revenue engine.

Oculis is advancing a neuroprotective drug for optic neuropathies and a first-of-its-kind eye drop for diabetic macular edema, aiming at $10B+ markets.

A newly validated genetic test accurately predicts melanoma risk, offering a non-invasive alternative to the standard surgical biopsy for many patients.

After a major win at CES 2026, a South Korean edtech firm is set to bring its revolutionary 'Visual LLM' learning platform to the US K-12 market.

Renowned scientist Eric Hoek becomes Executive Chairman at Active Membranes, aiming to commercialize a technology that could cut water treatment costs by 50%.

Pharma giant Bayer partners with biotech innovator Soufflé to develop a groundbreaking siRNA therapy, aiming to deliver genetic medicine directly to the heart.

The UK retail giant is ditching manual spreadsheets for an AI-driven platform to standardize labor and enhance customer experience across 240+ stores.

After success in Europe, Allotex gets FDA nod to begin U.S. trials for its tissue-based presbyopia treatment, offering new hope for millions.

A new clinical benchmark published in a Nature journal reveals a Chinese AI is the safest and most effective, challenging Silicon Valley's dominance.

At CES 2026, BLUETTI moves beyond portable power, unveiling smart home batteries, a sodium-ion first, and a vision for a decentralized energy grid.

At CES 2026, RobotEra's L7 humanoid and 'Hexa-Core' lineup showcase China's growing dominance in the global robotics race. Here's a deep dive.

At CES 2026, LumiMind's BCI tech promises to guide you to sleep and power thought-controlled games, raising major scientific and ethical questions.

Beyond the hype, X-Humanoid's robots are running marathons and working on production lines, signaling a major shift from lab demos to real-world deployment.

Ahrefs expands its Brand Radar to track YouTube, TikTok, and Reddit, aiming to give marketers a unified view of brand discovery in the age of AI.